Search results for "VOLUME"

showing 10 items of 1932 documents

Effect of cigarette smoking on airway responsiveness to adenosine 5'-monophosphate in subjects with allergic rhinitis.

2003

Study objectives: The objective of this study was to determine differences in airway responsiveness to adenosine 5-monophosphate (AMP) between smokers and nonsmokers with allergic rhinitis. Methods: A total of 41 adults with allergic rhinitis (16 smokers and 25 nonsmokers) were challenged with increasing concentrations of methacholine and AMP. Airflow was assessed after each concentration, and the response to each bronchoconstrictor agent was measured by the provocative concentration required to produce a 20% fall in FEV1 (PC20). Results: The geometric mean PC20 AMP values were significantly lower in smokers than in nonsmokers: 72.4 mg/mL (95% confidence interval [CI], 33.9 to 154.9) vs 204…

Pulmonary and Respiratory MedicineAdenosine monophosphateAdultMalemedicine.medical_specialtyAllergyRhinitis Allergic PerennialBronchoconstrictionBronchiCritical Care and Intensive Care MedicineBronchial Provocation Testschemistry.chemical_compoundInternal medicineForced Expiratory VolumeMedicineHumansInflammationbusiness.industrySmokingRhinitis Allergic Seasonalmedicine.diseaseAdenosinePathophysiologyConfidence intervalAdenosine Monophosphaterespiratory tract diseasesEndocrinologymedicine.anatomical_structurechemistrySpirometryMethacholineBronchoconstrictionFemalemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugRespiratory tractChest
researchProduct

Relationship between airway sensitivity to adenosine 5' monophosphate and the shape of the concentration-response curve to methacholine in subjects w…

2001

Abstract The objective of this study was to determine differences in airway sensitivity to adenosine 5′-monophosphate (AMP) between allergic rhinitis subjects with plateau and those without evidence of plateau on the concentration–response curves to methacholine. A total of 51 adults (38 subjects with allergic rhinitis and 13 healthy controls) were challenged with increasing concentrations of methacholine and AMP. The methacholine challenge was terminated when there was a 40% or more decrease in forced expiratory volume in 1 sec (FEV 1 ), whereas the AMP challenge was stopped when FEV 1 had fallen by more than 20%. A plateau for methacholine was detected in all 13 healthy controls and in 27…

Pulmonary and Respiratory MedicineAdenosine monophosphateSpirometryAdultMalemedicine.medical_specialtyAllergyRhinitis Allergic PerennialBronchoconstrictionVital CapacityBronchial Provocation TestsStatistics NonparametricBronchoconstrictor Agentschemistry.chemical_compoundmethacholine.adenosine 5′-monophosphateInternal medicineForced Expiratory VolumemedicineHumansMethacholine ChlorideAnalysis of Varianceallergic rhinitismedicine.diagnostic_testConcentration ResponseDose-Response Relationship Drugbusiness.industryRhinitis Allergic Seasonalmedicine.diseaseAdenosineAdenosine MonophosphateEndocrinologychemistryAnesthesiaCase-Control StudiesMethacholineBronchoconstrictionFemalemedicine.symptombusinessAirwaymedicine.drugRespiratory medicine
researchProduct

Effect throughout the day of inhaled fenoterol on the bronchial responsiveness to histamine in asthmatic patients.

1987

The effect throughout the day of inhaled fenoterol on the bronchial responsiveness to inhaled histamine was evaluated in 8 asthmatic patients. The airway response to increasing concentration of histamine aerosol was assessed by measurement of forced expiratory volume in one second (FEV1). The provocative dose of histamine needed to cause a 20% fall in starting FEV1 was calculated from the cumulative log dose response curves. Histamine challenges were performed in duplicate, on separate days, after premedication with placebo or fenoterol given by metered dose inhalers in the morning and in the afternoon. The mean starting FEV1 in the morning and in the afternoon did not change significantly …

Pulmonary and Respiratory MedicineAdultMaleAdolescentmedicine.drug_classHistamine AntagonistsBronchial Provocation Testschemistry.chemical_compoundBronchodilatorForced Expiratory VolumemedicineHumansCircadian rhythmFenoterolAsthmaFenoterolbusiness.industryRespiratory diseaserespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesCircadian RhythmBronchodilatationchemistryAnesthesiaImmunologyFemalebusinessAirwayHistaminemedicine.drugRespiration; international review of thoracic diseases
researchProduct

Outcome after mitral valve operations with depressed left ventricular function.

2012

We retrospectively investigated 42 patients (27 men, 15 women; mean age, 67 years) with severe mitral valve incompetence and endstage cardiomyopathy (ejection fraction <30%) who were operated on between January 2002 and March 2009. Of these, 14 were in New York Heart Association class IV, and 27 were in class III. The etiology was ischemic in 18 patients and idiopathic dilated in 24. Mitral valve repair was performed in 25 patients, and 17 had mitral valve replacement. The mean logistic EuroSCORE was 33.41. The mean follow-up was 44.52 months. There were no perioperative deaths. Three patients died within 30 days postoperatively. Thirty-day mortality was lower than predicted by EuroSCOR…

Pulmonary and Respiratory MedicineAdultMaleReoperationmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCardiomyopathyKaplan-Meier EstimateRisk AssessmentSeverity of Illness IndexVentricular Function LeftVentricular Dysfunction LeftRisk FactorsInternal medicineMitral valveGermanymedicineHumansCardiac Surgical ProceduresSurvival rateAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overHeart Valve Prosthesis ImplantationMitral valve repairEjection fractionbusiness.industryMitral valve replacementMitral Valve InsufficiencyEuroSCOREStroke VolumeGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureLogistic ModelsTreatment OutcomeMultivariate AnalysisCardiologyMitral ValveSurgeryFemaleCardiology and Cardiovascular MedicinebusinessCardiomyopathiesAsian cardiovascularthoracic annals
researchProduct

Effect of beclomethasone dipropionate on the bronchial responsiveness to propranolol in asthmatics.

1990

The effect of four weeks of treatment with beclomethasone dipropionate (BDP, 500 micrograms twice daily) on the bronchial responsiveness to propranolol was examined in 16 patients with mild asthma in a placebo-controlled, double-blind crossover study. Propranolol was inhaled in doubling concentrations and the results were expressed as the cumulative dose producing a 20 percent fall in FEV1 (PC20). After four weeks of treatment with BDP, the mean FEV1 increased from 82.0 percent predicted to 88.1 percent predicted. The difference was significant (p less than 0.001). Treatment with BDP did not significantly change the responsiveness to propranolol, the geometric mean PC20 being 3.17 mg/ml bef…

Pulmonary and Respiratory MedicineAdultMaleTime FactorsMild asthmaPropranololCritical Care and Intensive Care MedicineBronchial Provocation TestsRandom AllocationDouble-Blind MethodForced Expiratory VolumeAdministration InhalationmedicineAsthmatic patientHumansAsthmaBronchial SpasmCumulative dosebusiness.industryRespiratory diseaseBeclomethasonerespiratory systemmedicine.diseaseCrossover studyPropranololAsthmaAnesthesiaBronchoconstrictionFemalemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.

2011

SummaryRecommended treatment for moderate to severe asthma is the combination of an inhaled corticosteroid and a long-acting beta2-agonist. The present study was designed to evaluate the efficacy of a newly developed fixed combination of ciclesonide and formoterol in comparison to the marketed fixed combination of fluticasone and salmeterol in patients with moderate asthma.This was a phase II, multi-centre, randomized, parallel-group, double-blind, double-dummy study. After a 2-week run-in period, 160 patients with moderate asthma were randomized to a 6-week treatment with ciclesonide/formoterol 320/9 μg bid (CIC/F) or fluticasone propionate/salmeterol 250/50 μg bid (FP/S), both delivered a…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentUrologyCiclesonideCiclesonideFluticasone propionatechemistry.chemical_compoundYoung AdultDouble-Blind Methodimmune system diseasesPregnenedionesForced Expiratory VolumeFormoterol FumarateGermanyAdministration InhalationmedicineHumansFixed combinationAlbuterolFormoterolAnti-Asthmatic AgentsChildGlucocorticoidsFluticasoneAgedFluticasone-Salmeterol Drug Combinationbusiness.industryrespiratory systemMiddle AgedAsthmaFluticasone-Salmeterol Drug Combinationrespiratory tract diseasesBronchodilator AgentsAndrostadienesDrug CombinationsTreatment OutcomeTolerabilitychemistryEthanolaminesAustriaFormoterol FumarateFemaleSalmeterolFormoterolbusinessmedicine.drugRespiratory medicine
researchProduct

Smoking and Obesity Increase Airway Hyperesponsiveness Risk In the Elderly

2015

Objective of our study was assessing whether smoking and obesity might affect airways hyperresponsiveness (AHR) differently in younger and older subjects and whether this influence might be due to their different impacts on baseline lung function values at different ages. Methods 3,903 consecutive adult subjects with normal lung function (1,920 males; mean age 35.1±16.2; median FEV1:97.3% of predicted [interquartile range (IQR):89.7-105.2] and FEV1/FVC:84.6% of predicted [IQR:79.8-89.2]), having performed a methacholine test, were considered. They were subdivided into three groups according to age (18-39, 40-64 and ≥65 years) and into different sub-groups according to body mass index (BMI) …

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAgingAdolescentVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioBronchial Provocation Tests03 medical and health sciencesFEV1/FVC ratioYoung Adult0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineForced Expiratory VolumemedicineRespiratory HypersensitivityHumansObesityYoung adultMethacholine ChlorideAsthmaAgedRetrospective Studiesbusiness.industrySmoking030206 dentistryrespiratory systemMiddle Agedmedicine.diseaseObesityrespiratory tract diseases030228 respiratory systemPediatrics Perinatology and Child HealthPhysical therapyasthma agingMethacholineFemaleAirwaybusinessBody mass indexmedicine.drug
researchProduct

Effect of age upon airway obstruction and reversibility in adult patients with asthma.

1998

In a cross-sectional study we evaluated the effect of aging (separately from that of duration of disease) on airway obstruction and reversibility by comparing two groups of non-smoker patients with asthma.We compared two groups of patients: group A, which had 50 subjects (8 men and 42 women) aged 59.7+/-4.6 years (mean +/- SD), and group B, comprised of 51 subjects (19 men and 32 women) who were 35.7+/-7.4 years old. The groups were selected because of comparable baseline degree of obstruction (FEV1 % of predicted, 67.8+/-20.3 in group A; 73.0+/-19.6 in group B, NS) and duration of the disease (14.0+/-11.7 years vs 11.2+/-9.1, NS). Spirometric examination, with a bronchodilator test, was pe…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAgingmedicine.drug_classVital CapacityDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioCritical Care and Intensive Care MedicineGroup AGroup BBronchial Provocation TestsBronchodilatorForced Expiratory VolumemedicineHumansAsthmaAgedbusiness.industryRespiratory diseaseAirway obstructionMiddle Agedmedicine.diseaseAsthmaSurgeryAirway ObstructionBronchial Provocation TestAgeingSpirometryAnesthesiaRespiratory MechanicsFemaleCardiology and Cardiovascular MedicinebusinessHumanChest
researchProduct

Modifications of airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide concentrations after the pollen season in subjects with…

2002

s: To determine the effect of cessation of exposure to pollen on airway responsiveness to adenosine 5'-monophosphate (AMP) in subjects with pollen-induced rhinitis, and to explore the relationship between changes in airway responsiveness and changes in exhaled nitric oxide (ENO) levels.Subjects were studied during the pollen season and out of season.Specialist allergy unit in a university hospital.Fourteen subjects without asthma with pollen-induced rhinitis who showed bronchoconstriction in response to methacholine and AMP during the pollen season and 10 healthy nonatopic control subjects.In subjects with pollen-induced rhinitis, ENO concentrations, provocative concentration of agonist cau…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyBronchoconstrictionCritical Care and Intensive Care Medicinemedicine.disease_causeNitric OxideBronchial Provocation TestsNitric oxideCohort Studieschemistry.chemical_compoundInternal medicinePollenForced Expiratory Volumeotorhinolaryngologic diseasesmedicineHumansExpirationMethacholine ChlorideAsthmabusiness.industryfood and beveragesRhinitis Allergic Seasonalrespiratory systemmedicine.diseaseAdenosine Monophosphaterespiratory tract diseasesEndocrinologychemistryBreath TestsSpirometryImmunologyExhaled nitric oxidePollenMethacholineBronchoconstrictionFemalemedicine.symptomBronchial HyperreactivityCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Effect of body weight on the volume of distribution of theophylline.

1988

The volume of distribution (Vd) of theophylline and the relevant aminophylline loading dose (LD) are usually calculated on the basis of total body weight (TBW). In obese subjects it has been suggested that lean or ideal body weight (IBW) is the best predictor. In a sample of 40 acutely ill asthmatic patients (aged 22 to 78 yr, weighing 45 to 176 kg) we measured Vd and found that (1) it increases with TBW, (2) it cannot be accurately predicted from either TBW or IBW alone by a simple regression analysis. Power functions have been usefully applied in comparing the pharmacokinetics of animal species, including humans, with different body mass. In our sample, data were best fitted by the equati…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyBody weightLoading doseAnimal sciencePharmacokineticsTheophyllineInternal medicinemedicineHumansTheophyllineObesityAnimal speciesAgedVolume of distributionDose-Response Relationship Drugbusiness.industryBody WeightRegression analysisMiddle AgedAsthmaEndocrinologyRegression AnalysisAminophyllineFemalebusinessmedicine.drugLung
researchProduct